X 
Board Meetings
Home | Market Info | Company Profile | Board Meetings
Krishna Institute of Medical Sciences Ltd
BSE CODE: 543308   |   NSE CODE: KIMS   |   ISIN CODE : INE967H01025   |   24-Jul-2026 Hrs IST
BSE NSE
Rs. 797.25
15.4 ( 1.97% )
 
Prev Close ( Rs.)
781.85
Open ( Rs.)
784.60
 
High ( Rs.)
799.45
Low ( Rs.)
778.85
 
Volume
38511
Week Avg.Volume
87300
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs. 797.85
16.3 ( 2.09% )
 
Prev Close ( Rs.)
781.55
Open ( Rs.)
780.00
 
High ( Rs.)
799.90
Low ( Rs.)
779.05
 
Volume
792395
Week Avg.Volume
514985
 
52 WK High-Low Range(Rs.)
575.8
858
Source DateBoard Meeting DateDetails
10-Jun-2026 13-Jun-2026 Inter alia, to consider and approve:- (1) the proposal for raising of funds by way of issuance of one or more instrument(s) / securities which may include equity shares, fully convertible warrants and/or any other eligible securities (convertible / non-convertible) and / or any combinations of securities thereof through permissible modes, including but not limited to a preferential issue on a private placement basis or through any other permissible mode and / or combination thereof as may be considered appropriate
06-May-2026 15-May-2026 Audited Results
06-Mar-2026 11-Mar-2026 Rights Issue & Right Issue of Equity Shares & Inter alia, to consider and approve and evaluate the proposal for raising of funds by way of issuance of equity shares, in one or more tranches by way of one or more Qualified Institutions Placements ( QIP ) and/or rights issue in accordance with the applicable provisions of the Companies Act, 2013 and the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, (each as amended), or through any other permissible mode or any combination thereof, in such manner, and on such terms and conditions as may be deemed appropriate by the Board in its absolute discretion, subject to the receipt of necessary approvals, including the approval of the members of the Company and such other regulatory and statutory approvals as may be required, if any, as may be required and determination of the issue price.
02-Feb-2026 06-Feb-2026 Quarterly Results
24-Oct-2025 07-Nov-2025 Quarterly Results
24-Jul-2025 06-Aug-2025 Quarterly Results
02-May-2025 12-May-2025 Audited Results
27-Jan-2025 06-Feb-2025 Quarterly Results
25-Oct-2024 09-Nov-2024 Quarterly Results
25-Jul-2024 07-Aug-2024 Quarterly Results
Page 1 of 3
PREV || NEXT